Results 121 to 130 of about 986 (170)
Some of the next articles are maybe not open access.

Chemistry and pharmacology of nootropics

Drug Development Research, 1982
AbstractNicolaus, B.J.R.: Chemistry and pharmacology of nootropics. Drug Dev. Res. 2: 463–474, 1982.The paper discusses the chemistry and pharmacology of the nootropics, reviewing the new chemical entities to recently emerge and in particular the five‐membered heterocyclic lactams belonging to the pyrrolidinone class, such as piracetam and oxiracetam ...
exaly   +2 more sources

Nootropic supplements for esports

International Journal for Vitamin and Nutrition Research
Abstract: Background: esports, or organized video game competitions, have been expanding quickly. The use of dietary supplements by esports players appears vulgarized but lacks supporting evidence. Objectives: To outline studies that tested the effects of dietary supplements on video gaming, summarize their findings, highlight knowledge gaps, and ...
Fernando J. Ribeiro, Rui Poínhos
openaire   +4 more sources

Nootropics And Foods

1999
Food, diet, vitamins, trace elements, minerals, and additives have been part of folk treatments for mental disorders dating back to itinerant peddlers of snake oil. Foods are often touted by those outside the traditional medical mainstream as substitutes for established treatments.
C. Keith Conners, Elizabeth P. Sparrow
openaire   +1 more source

Nootropics

2002
Abstract The term ‘nootropics’ (from Greek, noos—mind, tropos—turn) was originally coined to denote chemical compounds that were reported to enhance cognitive function, including learning and memory, without possessing other significant effects (Giurgea 1973). The best known are piracetam and structurally related compounds (Giurgea 1973;
openaire   +1 more source

Piracetam and other structurally related nootropics

Brain Research Reviews, 1994
Nearly three decades have now passed since the discovery of the piracetam-like nootropics, compounds which exhibit cognition-enhancing properties, but for which no commonly accepted mechanism of action has been established. This review covers clinical, pharmacokinetic, biochemical and behavioural results presented in the literature from 1965 through ...
A H, Gouliaev, A, Senning
exaly   +3 more sources

Nootropic effects of ACE inhibitors in mice

Psychopharmacology, 1990
The angiotensin converting enzyme (ACE) inhibitors captopril and enalapril and the nootropic piracetam reduced the amnesiogenic effects of cerebral electroshock treatment in mice. These compounds also directly improved passive-avoidance learning if administered before the learning trial.
C, Mondadori, P, Etienne
openaire   +2 more sources

Towards Better Brain Management: Nootropics

Current Medicinal Chemistry, 2007
The learning and memory deficits have been recognized as severe and consistent neurological disorders associated with numerous neurodegenerative states. Research in this area has gained momentum only in the recent past after the biochemical and physiological basis of these processes have been understood.
Ruchi, Malik   +4 more
openaire   +2 more sources

Nootropic drugs and brain cholinergic mechanisms

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
1. This review has two aims: first, to marshal and discuss evidences demonstrating an interaction between nootropic drugs and brain cholinergic mechanisms; second, to define the relationship between the effects on cholinergic mechanisms and the cognitive process. 2.
G, Pepeu, G, Spignoli
openaire   +2 more sources

Nootropic activity of Albizzia lebbeck in mice

Journal of Ethnopharmacology, 2002
The effect of saponin containing n-butanolic fraction (BF) extracted from dried leaves of Albizzia lebbeck on learning and memory was studied in albino mice using passive shock avoidance paradigm and the elevated plus maze. Significant improvement was observed in the retention ability of the normal and amnesic mice as compared to their respective ...
S D, Chintawar   +3 more
openaire   +2 more sources

Nootropics

Journal of Clinical Psychopharmacology, 1994
openaire   +2 more sources

Home - About - Disclaimer - Privacy